Opendata, web and dolomites

MAGTEST

MAGTEST: Simple and specific next generation lab-on-a-chip in-vitro molecular diagnostic device

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MAGTEST project word cloud

Explore the words cloud of the MAGTEST project. It provides you a very rough idea of what is the project "MAGTEST" about.

bulky    bacteria    milk    human    judicious    substrate    2018    initially    winning    clear    devastating    sustainable    fast    compact    convenient    investment    diagnostic    time    economic    bacterial    accurate    significantly    status    kansas    gland    expressed    ipr    solutions    businesses    boost    too    magnomics    worth    magtest    antimicrobial    site    city    dna    mastitis    industrial    2016    infection    industry    validated    line    fundamental    disease    informative    biotechnology    deployment    identification    pipeline    proprietary    mammary       competitiveness    simply    introduction    07    detect    portable    either    operate    hindrances    commercialization    2015    forum    annual    margins    company    farms    smeinst    antibiotics    2bn    alone    efficient    innovation    vitro    industrialization    market    detection    dairy    producers    world    regards    crushing    health    resistances    device    parallel    danger    6bn    diagnostics    award    animal    reducing    tool    molecular    first    strategy    platform    2013    bovine    treatments    2017    till    cows   

Project "MAGTEST" data sheet

The following table provides information about the project.

Coordinator
MAGNOMICS SA 

Organization address
address: PARQUE TECNOLOGICO DE CANTANHEDE NUCLEO 04 LOTE 2
city: CANTANHEDE
postcode: 3060 197
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Portugal [PT]
 Project website http://www.magnomics.pt
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.2.4. (Sustainable and competitive bio-based industries and supporting the development of a European bioeconomy)
2. H2020-EU.3.2.1. (Sustainable agriculture and forestry)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.2.2. (Sustainable and competitive agri-food sector for a safe and healthy diet)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-08-01   to  2017-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MAGNOMICS SA PT (CANTANHEDE) coordinator 50˙000.00

Map

 Project objective

Antimicrobial resistances are a clear and present danger for human health. More than ever, it is fundamental to have an accurate and fast bacteria identification tool to ensure the judicious deployment of antibiotics.

Current diagnostic solutions are either too complex and bulky to operate “on site”, or are simply not informative enough. Magnomics novel, fast, award winning proprietary technology is able to detect bacterial DNA using a simple, compact platform. This fully portable, easy to use in-vitro molecular diagnostic device addresses the concerns expressed by the European Commission with regards to antimicrobial resistances: it allows for the easy and convenient detection of bacteria in any substrate, significantly reducing the lead time for treatments.

In line with the expected impact of the “SMEInst-07-2016-2017” topic, Magnomics will initially focus on animal health diagnostics. This choice of market, worth €2.6bn in 2013 with an 8% growth estimated till 2018, was fully validated after winning the Innovation Award at the Kansas City Animal Health Investment Forum in 2015. Addressing a devastating disease in dairy farms across the world that is crushing the margins of milk producers in the EU, the first product will target bovine mastitis, an infection of the mammary gland of dairy cows with an annual economic impact of over €2bn in the EU alone.

This technology is expected to significantly boost the competitiveness of the dairy industry through the reduction of health-related hindrances to production. In parallel, the milk production businesses will become more sustainable through the introduction of a high-end biotechnology process within their industrial pipeline, ensuring the efficient use of resources. MAGTEST will allow the company to fully assess the market potential, IPR status of Magnomics’ technology, ensuring an effective industrialization and commercialization strategy.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MAGTEST" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MAGTEST" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.2.4.;H2020-EU.3.2.1.;H2020-EU.2.3.1.;H2020-EU.3.2.2.)

Stoock (2018)

An Innovative Integrated Field Sensor system providing a precise farming tool to reduce productioncosts and water wastage.

Read More  

INDI (2018)

INDI, world’s first 100% dairy free, soy-free infant-formula.

Read More  

INSYLO (2018)

Disruptive IoT solution for optimising the animal feed supply chain

Read More